Telbivudine therapy may shape CD4+ T-cell response to prevent liver fibrosis in patients with chronic hepatitis B

Liver International

Volumn 35, Issue 3, 2015, Pages 834-845

  Li, Jing ^a,b   Jia, Minglei ^a   Liu, Yun ^a   She, Weimin ^a   Li, Lei ^a   Wang, Jiyao ^a   Jiang, Wei ^a  

^a FUDAN UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

Author keywords

CD4+ T subsets; Chronic hepatitis B; Hepatic stellate cells; Liver fibrosis; Telbivudine

Indexed keywords

HEPATITIS B(E) ANTIGEN; TELBIVUDINE; ANTIVIRUS AGENT; CYTOKINE; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA1; VIRUS DNA;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CELL PROLIFERATION ASSAY; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HUMAN; IMMUNE RESPONSE; LIVER FIBROSIS; MALE; MONOTHERAPY; PERIPHERAL BLOOD MONONUCLEAR CELL; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STELLATE CELL; TH1 CELL; TH17 CELL; TREATMENT OUTCOME; ADOLESCENT; ANALOGS AND DERIVATIVES; BLOOD; CASE CONTROL STUDY; CD4+ T LYMPHOCYTE; CELL CULTURE; COCULTURE; DOWN REGULATION; HEPATITIS B, CHRONIC; IMMUNOLOGY; LIVER CIRRHOSIS; MIDDLE AGED; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; DNA, VIRAL; DOWN-REGULATION; FEMALE; HEPATIC STELLATE CELLS; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION; YOUNG ADULT;

EID: 84922756184     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12589     Document Type: Article

References (27)

1. Papatheodoridis G, Buti M, Cornberg M, et al. European Association For The Study Of The Liver (EASL) Clinical Practice Guidelines: management of chronic hepatitis B virus infection. J Hepatol 2012; 57: 167-85.
2. Wang FS, Zhang Z. Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus. Expert Rev Gastroenterol Hepatol 2009; 3: 499-512.
3. Zhu J, Paul WE. Heterogeneity and plasticity of T helper cells. Cell Res 2010; 20: 4-12.
4. Nakayamada S, Takahashi H, Kanno Y, O'Shea JJ. Helper T cell diversity and plasticity. Curr Opin Immunol 2012; 24: 297-302.
5. Yang XO, Nurieva R, Martinez GJ, et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008; 29: 44-56.
6. Bertoletti A, Ferrari C. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection. Gut 2012; 61: 1754-64.
7. Stoop JN, van der Molen RG, Baan CC, et al. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 2005; 41: 771-8.
8. Peng G, Li S, Wu W, et al. Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection. Immunology 2008; 123: 57-65.
9. Zhang JY, Zhang Z, Lin F, et al. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 2010; 51: 81-91.
10. Marra F, Aleffi S, Galastri S, Provenzano A. Mononuclear cells in liver fibrosis. Semin Immunopathol 2009; 31: 345-58.
11. Li J, Qiu SJ, She WM, et al. Significance of the balance between regulatory T (Treg) and T helper 17 (Th17) cells during hepatitis B virus related liver fibrosis. PLoS ONE 2012; 7: e39307.
12. Sun HQ, Zhang JY, Zhang H, et al. Increased Th17 cells contribute to disease progression in patients with HBV-associated liver cirrhosis. J Viral Hepat 2012; 19: 396-403.
13. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008; 134: 1655-69.
14. Winau F, Hegasy G, Weiskirchen R, et al. Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 2007; 26: 117-29.
15. Ma SW, Huang X, Li YY, et al. High serum IL-21 levels after 12 weeks of antiviral therapy predict HBeAg seroconversion in chronic hepatitis B. J Hepatol 2012; 56: 775-81.
16. Weng YQ, Qiu SJ, Liu YK, et al. Down-regulation of beta-centractin might be involved in dendritic cells dysfunction and subsequent hepatocellular carcinoma immune escape: a proteomic study. J Cancer Res Clin Oncol 2008; 134: 179-86.
17. Zhang JY, Song CH, Shi F, et al. Decreased ratio of Treg cells to Th17 cells correlates with HBV DNA suppression in chronic hepatitis B patients undergoing entecavir treatment. PLoS ONE 2010; 5: e13869.
18. Akbar SM, Horiike N, Chen S, et al. Mechanism of restoration of immune responses of patients with chronic hepatitis B during lamivudine therapy: increased antigen processing and presentation by dendritic cells. J Viral Hepat 2011; 18: 200-5.
19. Chen Y, Li X, Ye B, et al. Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B. Antiviral Res 2011; 91: 23-31.
20. Niu Y, Liu H, Yin D, et al. The balance between intrahepatic IL-17(+) T cells and Foxp3 (+) regulatory T cells plays an important role in HBV-related end-stage liver disease. BMC Immunol 2011; 12: 47-55.
21. Wang W, Shao S, Jiao Z, et al. The Th17/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis. Rheumatol Int 2012; 32: 887-93.
22. Lai CL, Gane E, Liaw YF, et al. Telbivudine vs. lamivudine in patients with chronic hepatitis B. N Engl J Med 2007; 357: 2576-88.
23. Liaw YF, Gane E, Leung N, et al. 2-year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B. Gastroenterology 2009; 136: 486-95.
24. Ma L, Cai YJ, Yu L. Treatment with telbivudine positively regulates antiviral immune profiles in Chinese patients with chronic hepatitis B. Antimicrob Agents Chemother 2013; 57: 1304-11.
25. Vinas O, Bataller R, Sancho-Bru P, et al. Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation. Hepatology 2003; 38: 919-29.
26. Yu MC, Chen CH, Liang X, et al. Inhibition of Tcell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice. Hepatology 2004; 40: 1312-21.
27. Chen CH, Kuo LM, Chang Y, et al. In vivo immune modulatory activity of hepatic stellate cells in mice. Hepatology 2006; 44: 1171-81.